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A B S T R A C T   
Background: Exercise has the potential to improve physical function and quality of life in individuals with bone 
metastases but is often avoided due to safety concerns. This systematic review summarizes the safety, feasibility 
and efficacy of exercise in controlled trials that include individuals with bone metastases. 
Methods: MEDLINE, Embase, Pubmed, CINAHL, PEDro and CENTRAL databases were searched to July 16, 2020. 
Results: A total of 17 trials were included incorporating aerobic exercise, resistance exercise or soccer in-
terventions. Few (n = 4, 0.5%) serious adverse events were attributed to exercise participation, with none related 
to bone metastases. Mixed efficacy results were found, with exercise eliciting positive changes or no change. The 
majority of trials included an element of supervised exercise instruction (n = 16, 94%) and were delivered by 
qualified exercise professionals (n = 13, 76%). 
Conclusions: Exercise appears safe and feasible for individuals with bone metastases when it includes an element 
of supervised exercise instruction.   
1. Introduction 
Preservation of physical function is a key objective of cancer reha-
bilitation in patients with advanced cancer (Cheville et al., 2016; Padgett 
et al., 2018). The presence of bone metastases can lead to abrupt and 
clinically significant declines in physical function and overall perfor-
mance status, which has been associated with increased healthcare uti-
lization, reduced quality of life and fewer treatment options (Silver et al., 
2013; Kurtz et al., 2005; Ten Tusscher et al., 2019; Maltser et al., 2017). 
Regular exercise (e.g. aerobic and resistance exercise) has been shown to 
improve measures of physical function in cancer patients and is 
recommended as an effective supportive care strategy (Campbell et al., 
2019; Hayes et al., 2019; Cormie et al., 2018; Support, 2018). However, 
exercise is often underutilized by medical professionals for patients with 
bone metastases due to uncertainties around safety and the overall risk of 
skeletal-related events (SREs) associated with bone metastases, including 
pathological fracture and spinal cord compression (Cheville et al., 2011; 
Silver et al., 2018; Sheill et al., 2018a; Ten Tusscher et al., 2020). In 
contrast, patients with bone metastases have expressed interest in 
receiving exercise information and participating in exercise programs, 
highlighting the need for evidence-informed guidance on exercise as a 
therapeutic intervention in this setting (Ten Tusscher et al., 2019; Delrieu 
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et al., 2019; Lowe et al., 2010; Sheill et al., 2018b). 
Previous systematic reviews on exercise in people with advanced 
cancer exist, yet to our knowledge, none have primarily focused on par-
ticipants with bone metastases (Heywood et al., 2018; Nadler et al., 2019; 
Beaton et al., 2009; Dittus et al., 2017; Lowe et al., 2009; Titz et al., 2016; 
Salakari et al., 2015). A meta-analysis by Nadler et al. evaluating exercise 
interventions in individuals with advanced cancer included a sub-group 
analysis from six trials that included some participants with bone me-
tastases and concluded that exercise was likely safe if it was supervised 
and individually tailored (Nadler et al., 2019). The authors note that the 
appropriateness and safety of unsupervised exercise is currently unclear 
due to lack of randomized controlled trials (RCTs) that include partici-
pants with bone metastases in exercise interventions (Nadler et al., 2019). 
Given the risk of SREs associated with bone metastases and the 
negative consequences elicited by poor physical function, it is important 
to establish the safety and efficacy of exercise specific to individuals 
with bone metastases across supervised and unsupervised settings 
(Sturgeon et al., 2019; Coleman, 2006; Healey and Brown, 2000). To 
effectively design and implement exercise within clinical settings, it is 
also critical to understand exercise feasibility (El-Kotob and Gian-
gregorio, 2018). To address this gap in the knowledgebase, we con-
ducted a systematic review to summarize and qualitatively assess the 
safety, feasibility and efficacy of exercise in controlled trials that include 
individuals with bone metastases. 
2. Methods 
2.1. Literature Search 
Preferred Reporting Items for Systematic Reviews and Meta-analysis 
(PRISMA) (Moher et al., 2009) reporting guidelines were followed and 
registration with PROSPERO (CRD42019121958). Electronic databases 
(MEDLINE, Embase, Pubmed, CINAHL, PEDro and CENTRAL) were 
searched from inception to 16 July 2020, using a search strategy 
developed in consultation with a university librarian. Additionally, grey 
literature and reference lists of eligible papers were searched. The search 
included subject headings or keywords for “cancer” and “bone metas-
tases or advanced cancer” and “exercise” (eSupplement eTable 1). Limits 
included human participants and publication in English. 
2.2. Eligibility Criteria 
Inclusion criteria were: 1) design: RCT or controlled clinical trial; 2) 
population: 18-years or older with a diagnosis of cancer; sample included 
participants with metastatic bone disease (with confirmed number of 
participants with bone metastases); 3) intervention: any exercise inter-
vention comprising more than one session of structured exercise; 4) 
comparator group: usual care, control or comparator interventions; and 
5) outcome: at least one outcome related to efficacy on physical function 
(e.g., sit to stand), functional capacity (e.g., cardiopulmonary exercise 
test), muscular strength (e.g., one repetition maximum) or treatment side 
effect (e.g., fatigue). Exercise was operationally defined as aerobic, 
resistance or flexibility exercise, sports-specific training (e.g., soccer), 
yoga, tai chi, Pilates or a combination of any of these modalities. Struc-
tured exercise refers to an exercise prescription given to be performed in 
a supervised or unsupervised setting. 
2.3. Trial Selection, Data Extraction and Synthesis 
Citations yielded from the search were exported to Endnote (Clar-
ivate Analytics, Philadelphia, PA) and duplicates were removed (Bramer 
et al., 2016). Title and abstract screening was performed by two review 
teams (SW and SM; KAB and NHH). Two reviewers (SW and NHH) 
independently performed full-text screenings. Data was extracted using 
a standard form that included sample and intervention characteristics 
(age, presence of bone metastases, exercise prescription, supervision 
characteristics), safety (adverse events, exclusion criteria, exercise 
modifications), feasibility (recruitment, attendance, study retention, 
adherence), and efficacy outcomes (between group mean differences, 
95% confidence intervals and p-values). Two reviewers (SW and NHH) 
independently assessed risk of bias using Cochrane Risk of Bias 2.0 for 
RCTs and Risk of Bias In Non-Randomized Studies of Interventions, 
identifying “high risk”, “some concerns” and “low risk” of bias of each 
trial (Sterne et al., 2019; Sterne et al., 2016). Disagreements were dis-
cussed and resolved. Corresponding authors of included trials were 
contacted when additional information was required. 
Descriptive statistics including mean, standard deviation (SD) & 
range were generated with SPSS v25 (IBM Corporation; Chicago, IL, 
USA) to summarize data from eligible trials. A separate descriptive 
analysis was conducted for trials that only included individuals with 
bone metastases. For trials that included individuals with and without 
bone metastases, results of the total sample are presented. 
3. Results 
3.1. Overview 
A total of 12,781 records were identified through the database search 
and 24 publications met the eligibility criteria, representing 17 trials 
(eSupplement, eFig. 1). Of the excluded trials, 11 did not record the 
number of participants who had bone metastases and were therefore 
excluded. Of the included trials, one trial was a controlled clinical trial 
(Rosenberger et al., 2017) and the remaining 16 were RCTs (Bjerre et al., 
2019a, b; Bourke et al., 2011, 2014; Cheville et al., 2019; Cormie et al., 
2013; Dawson et al., 2018; Galvão et al., 2018; Litterini et al., 2013; Rief 
et al., 2014a, b, c, d, 2016; Scott et al., 2018; Solheim et al., 2017; Sprave 
et al., 2019; Uster et al., 2018; Uth et al., 2014, 2016a, b; Villumsen 
et al., 2019; Yee et al., 2019). Four (24%) trials included only partici-
pants with bone metastases (Cormie et al., 2013; Galvão et al., 2018; 
Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019), and the remaining 
13 (76%) trials included participants with and without bone metastases. 
A total of 1489 participants were included in our review, of which 645 
(43%) had bone metastases and 845 (57%) were assigned to an exercise 
intervention group. The mean (SD) participant age was 65 (5) years. 
Trials recruited participants with prostate cancer (n = 8, 47%) (Bjerre 
et al., 2019a, b; Bourke et al., 2011, 2014; Cormie et al., 2013; Dawson 
et al., 2018; Galvão et al., 2018; Uth et al., 2014, 2016a, b; Villumsen 
et al., 2019), breast cancer (n = 2, 12% (Scott et al., 2018, Yee et al., 
2019)) or mixed tumor types (n = 7, 41%) (Cheville et al., 2019; Litterini 
et al., 2013; Rief et al., 2014a, b, c, d, 2016; Rosenberger et al., 2017; 
Solheim et al., 2017; Sprave et al., 2019; Uster et al., 2018). 
Five (29%) trials had a low risk of bias (Bjerre et al., 2019a, b; 
Cheville et al., 2019; Dawson et al., 2018; Scott et al., 2018; Sprave et al., 
2019), ten (59%) had some concerns (Bourke et al., 2011, 2014; Cormie 
et al., 2013; Galvão et al., 2018; Rosenberger et al., 2017; Solheim et al., 
2017; Uster et al., 2018; Uth et al., 2014, 2016a, b; Villumsen et al., 
2019; Yee et al., 2019), and two (13%) had a high risk of bias (Litterini 
et al., 2013; Rief et al., 2014a, b, c, d, 2016) (Fig. 1). Risk of bias con-
cerns were predominantly due to a lack of published trial protocol or 
detailed trial registration (Bourke et al., 2011, 2014; Cormie et al., 2013; 
Litterini et al., 2013; Solheim et al., 2017; Yee et al., 2019), absence of 
appropriate analysis to measure between group effect (Galvão et al., 
2018; Rief et al., 2014a, b, c, d, 2016; Uster et al., 2018; Uth et al., 2014, 
2016a, b; Villumsen et al., 2019), unequal dropout between study arms 
that may have influenced results (Litterini et al., 2013; Rosenberger 
et al., 2017), and selection bias of reported results across multiple 
publications (Rief et al., 2014a, b, c, d, 2016). 
3.2. Intervention Characteristics 
The exercise intervention characteristics (i.e., frequency, intensity, 
time, type, duration) of each trial are described in Table 1 (additional 
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information eSupplement eTable 2). Overall, 14 (82%) trials prescribed 
resistance exercise (resistance exercise only, n = 8; resistance and aer-
obic exercise, n = 6), two trials prescribed aerobic exercise alone (Lit-
terini et al., 2013; Scott et al., 2018) and two trials evaluated a soccer 
intervention (Bjerre et al., 2019a, b; Uth et al., 2014, 2016). In studies 
including resistance exercise, 12 (86%) trials prescribed whole body 
resistance training (Bourke et al., 2011, 2014; Cheville et al., 2019; 
Cormie et al., 2013; Dawson et al., 2018; Galvão et al., 2018; Litterini 
et al., 2013; Rosenberger et al., 2017; Solheim et al., 2017; Uster et al., 
2018; Villumsen et al., 2019; Yee et al., 2019) and two (14%) trials 
prescribed isometric spinal stabilization exercises with holds of 20-sec-
onds or greater per exercise (Rief et al., 2014a, b, c, d, 2016; Sprave 
et al., 2019). Comparator groups included usual care (n = 12, 71%), 
attention control (n = 4, 24%) (Dawson et al., 2018; Rief et al., 2014a, b, 
c, d, 2016; Scott et al., 2018; Sprave et al., 2019), or an alternate exercise 
modality (e.g., resistance versus aerobic exercise) (n = 1, 6%) (Litterini 
et al., 2013). Fifteen (88%) trials used moderate-to-vigorous intensity 
aerobic and/or resistance exercise prescriptions. 
Inclusion of at least one session of supervised exercise was a 
component of all but one (93%) trial (Solheim et al., 2017). Nine (53%) 
trials included only supervised exercise sessions (Bjerre et al., 2019a, b; 
Cormie et al., 2013; Dawson et al., 2018; Galvão et al., 2018; Litterini 
et al., 2013; Rosenberger et al., 2017; Scott et al., 2018; Uster et al., 
2018; Uth et al., 2014, 2016a,b), five (29%) trials included a combi-
nation of supervised and unsupervised exercise (Bourke et al., 2011, 
2014, Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019; Yee et al., 
2019), one (6%) trial included a single exercise demonstration session 
followed by unsupervised exercise (Villumsen et al., 2019), one (6%) 
trial included unsupervised exercise only with distanced-based tele-
phone check ins and optional in-person physical therapy sessions 
(Cheville et al., 2019) and one (6%) trial was entirely unsupervised 
(Solheim et al., 2017). Overall, unsupervised exercise was included with 
892 (60% of total) participants. Exercise supervision was predominantly 
provided by qualified exercise professionals (n = 13, 76%) including 
Fig. 1. Risk of Bias of included studies. 1a Risk of bias, all included trials, as percentage. 1b Risk of bias, individual trials.  
S. Weller et al.                                                                                                                                                                                                                                   
Critical Reviews in Oncology / Hematology 166 (2021) 103433
4
physical therapists/physiotherapists (n = 6, 35%) (Cheville et al., 2019; 
Litterini et al., 2013; Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019; 
Uster et al., 2018; Villumsen et al., 2019), clinical exercise physiologists 
(n = 6, 35%) (Bourke et al., 2011, 2014; Cormie et al., 2013; Galvão 
et al., 2018; Scott et al., 2018; Sprave et al., 2019) or other university 
trained exercise professionals (e.g., kinesiologists or sports therapists) (n 
= 3, 18%) (Litterini et al., 2013; Yee et al., 2019; Rosenberger et al., 
2017). 
3.3. Safety 
All but one trial reported on adverse events (AEs) (Bourke et al., 
2011), with nine (53%) trials measuring AEs in both intervention and 
comparator groups and seven (41%) trials measuring AEs in the inter-
vention group only (Table 2). Seven (41%) trials reported use of a 
comprehensive classification tool that specified AE grade and severity 
(e.g., National Cancer Institute Common Terminology Criteria for 
Adverse Events). Overall, three trials (18%) reported serious adverse 
events (SAEs) associated with the trial and all included samples with and 
without bone metastases (Bjerre et al., 2019a, b; Solheim et al., 2017; 
Uth et al., 2014, 2016a, b). A total of 57 SAEs were reported in these 
three trials; 27 SAEs occurred in intervention group participants and 30 
SAEs occurred in control group participants. Only four SAEs (0.5% of 
total exercise intervention participants) were attributed to an exercise 
intervention, all of which were attributed to soccer and were not related 
to bone metastases. One trial by Uth et al. reported three SAEs that 
included two fibula fractures and one partial achilles tendon rupture 
(Uth et al., 2014, 2016a, b). A second trial by Bjerre et al. reported 33 
SAEs resulting in hospital admission, 11 in the intervention group and 
22 in the usual care group, with one SAE attributed to the intervention, 
which was a soft-tissue injury that was not related to bone metastases 
(Bjerre et al., 2019a, b). Of note, in the four trials that exclusively 
included individuals with bone metastases, no SAEs occurred during the 
trials (Cormie et al., 2013; Galvão et al., 2018; Rief et al., 2014a, b, c, d, 
2016; Sprave et al., 2019). Additionally, one trial reported specifically 
on the presence of pathological fractures and found no significant 
differences between the intervention and control groups at baseline 
(23% vs 30%, p = 0.56) or end of intervention (23% vs 30%, p = 0.59%) 
(Rief et al., 2014a, b, c, d, 2016). 
Key to interpreting safety, criteria specific to inclusion and exclusion 
of participants with bone metastases is outlined in Table 3. Nine trials 
(53%) used exclusion criteria specific to bone metastases, namely 
excluding individuals presenting with unstable bone metastases (n = 4, 
24%) (Bourke et al., 2011, 2014, Rief et al., 2014a, b, c, d, 2016; 
Rosenberger et al., 2017) or pain associated with the bone lesion (n = 7, 
41%) (Bourke et al., 2011, 2014; Cormie et al., 2013; Galvão et al., 2018; 
Uster et al., 2018; Uth et al., 2014, 2016a, b; Yee et al., 2019). Four 
(24%) trials used inclusion criteria that required a physician clearance 
(Bjerre et al., 2019a, b; Cormie et al., 2013; Dawson et al., 2018; Litterini 
et al., 2013) and eight (47%) trials required a minimum performance 
status that included ambulation and basic self-care (i.e., Eastern Coop-
erative Oncology Group [ECOG] performance status 0 – 1/2; Karnofsky 
performance status [KPS] >70) (Rief et al., 2014a, b, c, d, 2016; Rose-
nberger et al., 2017; Scott et al., 2018; Solheim et al., 2017; Sprave et al., 
2019; Uster et al., 2018; Villumsen et al., 2019; Yee et al., 2019). Three 
(18%) trials specifically included higher risk populations that presented 
with pain related to the lesion site (Rief et al., 2014a, b, c, d, 2016), 
functional impairments (Cheville et al., 2019) or unstable bone metas-
tases (i.e., high fracture risk) (Sprave et al., 2019). 
Exercise prescription modifications specific to bone metastases were 
used in seven (41%) trials (eSupplement eTable 3) (Cheville et al., 2019; 
Cormie et al., 2013; Dawson et al., 2018; Galvão et al., 2018; Litterini 
et al., 2013; Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019). Three 
(18%) trials in men with prostate cancer prescribed resistance exercises 
that minimized loading to the lesion area (e.g., avoided horizontal press 
exercises when lesion present in thoracic spine) (Dawson et al., 2018; 
Cormie et al., 2013; Galvão et al., 2018). Four (24%) trials in individuals 
with mixed tumor types used other exercise modification approaches (e. 
g., using resistance bands instead of machines) (Cheville et al., 2019; 
Litterini et al., 2013; Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019). 
The remaining ten trials (59%) did not report exercise modifications 
specific to bone-metastases and included soccer, resistance exercise and 
Table 1 
Overview of included trials.  
Source Cancer Type Sample/ 
MBD (%) 
Intervention Significant findings of exercise intervention (between-group) 
Bjerre et al., 2019a, b Prostate 214/41 
(19%) 
Soccer vs UC Improved mental health. 
Bourke et al., 2011 Adv Prostate 50/13 (25%) AET, RT & Diet vs UC Improved exercise tolerance, physical function, strength, 
fatigue. 
Bourke et al., 2014 Adv Prostate 100/20 
(20%) 
AET, RT & Diet vs UC Improved QoL, exercise tolerance, fatigue. 
Cheville et al., 2019 Mixed Adv 
516/264 
(51%) 
(1a) AET & RT & PT vs (1b) +/- pain 
management vs control 
(1a) improved physical function, QoL, discharge time, LOS, 
pain interference. 
(1b) improved discharge home, pain interference. 
Cormie et al., 2013 Adv Prostate 
20/20 
(100%) RT vs UC Improved physical function, strength, body composition. 
Dawson et al., 2018 Prostate 35/13 (13%) RT vs control (stretch) Improved QoL, strength, body composition. 
Galvão et al., 2018 Adv Prostate 
57/57 
(100%) 
AET, RT & Flex vs UC Improved physical function, strength. 
Litterini et al., 2013 Mixed Adv 66/16 (24%) AET vs RT No change. 
Rief et al., 2014a, b, c, d, 
2016 
Mixed Adv 60/60 (!00%) RT vs Control (breathing) Improved physical function, body composition, pain score. 
Rosenberger et al., 2017 Mixed Adv 25/6 (24%) RT vs UC Improved body composition, strength. 
Scott et al., 2018 Adv Breast 65/17 (26%) AET vs Control (stretch) No change. 
Solheim et al., 2017 
Adv Lung & 
Panc. 46/8 (17%) AET & RT vs UC Improved body composition. 
Sprave et al., 2019 Mixed Adv 60/60 
(100%) 
RT vs Control (muscle relax) No change. 
Uster et al., 2018 Mixed Adv 58/14 (24%) AET, RT & Diet vs UC No change. 
Uth et al., 2014, 2016a, b Adv Prostate 57/11 (19%) Soccer vs UC Improved body composition, strength. 
Villumsen et al., 2019 Adv Prostate 46/16 (35%) Exergaming vs UC Improved physical function. 
Yee et al., 2019 Adv Breast 14/9 (62%) AET & RT vs UC Improved QoL, fatigue, physical function. 
Abbreviations: Adv = advanced; AET = aerobic exercise training; Flex = flexibility training; LOS = length of stay; Panc = Pancreatic; QoL = quality of life; RT =
resistance training; UC = usual care. 
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aerobic exercise interventions (Bjerre et al., 2019a, b; Bourke et al., 
2011, 2014; Rosenberger et al., 2017; Scott et al., 2018; Solheim et al., 
2017; Uster et al., 2018; Uth et al., 2014, 2016a, b; Villumsen et al., 
2019; Yee et al., 2019). 
3.4. Study Feasibility 
Participant recruitment, attendance, study retention and adherence 
are reported in Fig. 2 (additional information eSupplement eTable 4). 
Overall, mean (SD) recruitment rate was 46(25)%, ranging from 12% to 
93%. Trials exclusive to individuals with bone metastases reported mean 
recruitment rates of 64(12)% compared to mixed trials of 40(26)%. 
Mean attendance was 75(12)% across all trials, ranging from 59% to 
100%, with supervised trials reporting attendance of 79(14)% and un-
supervised trials 66(20)%. Trials exclusive to individuals with bone 
metastases reported mean attendance rates of 79(12)% compared to 
mixed trials 74(12)%. Mean retention was 83(10)% during the trial 
period, ranging from 53% to 100%. Trials exclusive to individuals with 
bone metastases reported mean retention rates of 74(14)% compared to 
mixed trials of 86(7)%. Adherence to the exercise intervention was only 
reported in eight trials, each measuring adherence differently, making it 
difficult to report the exercise intensity and duration completed (Bjerre 
et al., 2019a, b; Cormie et al., 2013; Dawson et al., 2018; Rosenberger 
et al., 2017; Scott et al., 2018; Solheim et al., 2017; Villumsen et al., 
2019; Yee et al., 2019). 
Table 3 
Participant inclusion and exclusion criteria of included trials   
Physician Clearance (n = 4) Painful Metastases (n = 7) Unstable Metastases (n = 4) Function Impairment (n = 8) 
Bjerre et al., 2019a, b Inclusion X X X 
Bourke et al., 2011 X Exclusion Exclusion X 
Bourke et al., 2014 X Exclusion Exclusion X 
Cheville et al., 2019 X X X Inclusion 
Cormie et al., 2013 Inclusion Exclusion X X 
Dawson et al., 2018 Inclusion X X X 
Galvão et al., 2018 X Exclusion X X 
Litterini et al., 2013 Inclusion X X X 
Rief et al., 2014a, b, c, d, 2016 X Inclusion Exclusion KPS <70 
Rosenberger et al., 2017 X X Exclusion ECOG >2 
Scott et al., 2018 X X X ECOG >1 
Solheim et al., 2017 X X X KPS <70 
Sprave et al., 2019 X X Inclusion KPS <70 
Uster et al., 2018 X Exclusion X ECOG >2 
Uth et al., 2014, 2016a, b X Exclusion X X 
Villumsen et al., 2019 X X X ECOG >2 
Yee et al., 2019 X Exclusion X ECOG >2 
Abbreviations: X = criteria not used; Inclusion = Required for participant to be included in trial; Exclusion = If present, criteria excluded participant from trial. 
Fig. 2. Feasibility of all trials included in systematic review, mean (SD) %.  
Table 2 
Safety considerations and outcomes of included studies  
Source AE 
Reporting 
AE Criteria Total SAEs Reported (I/C) Total AEs Reported (I/C) 
Bjerre et al., 2019a, b I & C GCP Guidelines 33 (11/12) 1 related to exercisea Falls 26 (10/6) Fractures 3 (1/2) Injuries 60 (60/0) 
Bourke et al., 2011 Not 
Reported 
NA NA NA 
Bourke et al., 2014 I & C None 0 0 
Cheville et al., 2019 I & C None 0 0 
Cormie et al., 2013 I & C 
None. Incidence & 
severity. 0 
Increased bone pain 1 (1/0) 
Adv disease 2 (1/1) 
Fall (home) 1 (1/0) 
Dawson et al., 2018 I only NCI CTCAE v4.3 0 0 
Galvão et al., 2018 I only 
None. Incidence & 
severity. 0 0 
Litterini et al., 2013 I only None 0 0 
Rief et al., 2014a, b, c,  
d, 2016 
I & C GCP Guidelines 0 0 
Rosenberger et al., 2017 I only None 0 Weakness, pain or injury 11 (11/NR) 
Scott et al., 2018 I & C MedDRA 0 73% of AET group had AE (e.g., abnormal HR 
response, fatigue, back pain) 
Solheim et al., 2017 I & C NCI CTCAE v3.0 21 (13/8)None related to exercise Grade 3 (e.g., pain, infection) 12 (7/5) 
Sprave et al., 2019 I & C NCI CTCAE v4.03 0 0 
Uster et al., 2018 I only None 0 0 
Uth et al., 2014, 2016a,  
b 
I only None 
3 (3/NR) 3 related to exercisea [Fractured fibula = 2, 
Partial Achilles rupture = 1] 
Muscle strain 1 (1/NR) 
Villumsen et al., 2019 I & C None 0 Chest pain, non-heart related 1 (1/0) 
Yee et al., 2019 I only NCI CTCAE v4.0 0 0  
a Not related to bone metastases; Abbreviations: AE = adverse event; C = Control group; GCP = Good Clinical Practice; I = intervention group; NCI CTCAE =
National Cancer Institute Common Terminology Criteria for Adverse Events; NR = Not reported; SAE = serious adverse event. 
S. Weller et al.                                                                                                                                                                                                                                   
Critical Reviews in Oncology / Hematology 166 (2021) 103433
6
3.5. Efficacy 
Across all 17 trials, no significant negative effects of the exercise 
intervention were reported in any efficacy outcome (Table 1, eSupple-
ment eTable 2). A variety of patient reported outcomes and objective 
test measures were used. A summary of the between-group efficacy re-
sults of each trial is shown in eSupplement eFig. 2. Significant between 
group improvement in physical function, fatigue and quality of life that 
favour exercise was reported in seven (54%) trials (Bourke et al., 2011; 
Cheville et al., 2019; Cormie et al., 2013; Galvão et al., 2018; Rief et al., 
2014a, b, c, d, 2016; Villumsen et al., 2019; Yee et al., 2019), three 
(23%) trials (Bourke et al., 2011, 2014; Yee et al., 2019) and four (31%) 
trials (Bourke et al., 2014; Cheville et al., 2019; Dawson et al., 2018; Yee 
et al., 2019), respectively. Significant between group improvements in 
body composition and objective measures of muscular strength that 
favour exercise was reported in six (43%) trials (Cormie et al., 2013; 
Dawson et al., 2018; Rief et al., 2014a, b, c, d, 2016; Rosenberger et al., 
2017; Solheim et al., 2017; Uth et al., 2014, 2016a, b) and six (67%) 
trials (Bourke et al., 2011; Cormie et al., 2013; Dawson et al., 2018; 
Galvão et al., 2018; Rosenberger et al., 2017; Uth et al., 2014, 2016a, b), 
respectively. Finally, significant between group reductions in pain that 
favour exercise was reported in two (29%) trials (Cheville et al., 2019; 
Rief et al., 2014a, b, c, d, 2016). 
In trials that exclusively included individuals with bone metastases 
(n = 4), results were mixed and a range of test measures were used 
(eSupplement eTable 2). Three (75%) trials (Cormie et al., 2013; Galvão 
et al., 2018; Rief et al., 2014a, b, c, d, 2016) reported significant 
between-group improvements in physical functioning that favour exer-
cise and two (50%) trials (Cormie et al., 2013; Galvão et al., 2018) re-
ported significant between-group improvements in muscle strength that 
favour exercise. All trials measured pain (n = 4), with one (25%) trial 
(Rief et al., 2014a, b, c, d, 2016) reporting a reduction in pain levels and 
three (75%) trials (Cormie et al., 2013; Galvão et al., 2018; Sprave et al., 
2019) reporting no difference between groups. No significant between 
group exercise effect was reported for fatigue (n = 4) or quality of life (n 
= 3) (Cormie et al., 2013; Rief et al., 2014a, b, c, d 2016; Sprave et al., 
2019). 
4. Discussion 
This systematic review supports that exercise is feasible in in-
dividuals with bone metastases and that participation in aerobic and 
resistance exercise does not appear to result in SAEs related to exercise. 
Soccer participation was associated with a small number of SAEs related 
to exercise (n = 4), however, none of these were related to the presence 
of bone metastases. Mixed efficacy results were found, with no negative 
effects of exercise reported. Participation in structured exercise showed 
an overall trend toward increasing physical function and muscular 
strength across all trials (54%, 67% respectively) and in trials exclusive 
to individuals with bone metastases (75%, 50% respectively). 
Establishing the safety profile of exercise interventions for patients 
with bone metastases is a key consideration to enable medical pro-
fessionals to advise on exercise suitability (Sheill et al., 2018a; Silver 
et al., 2015). The studies included in this systematic review reported no 
SAEs in interventions prescribing aerobic and/or resistance exercise that 
included at least one session of supervised exercise instruction. Partici-
pation in aerobic and resistance exercise did not appear to increase the 
rate of pathological fracture, pain or use of pain medication. The few 
SAEs reported were attributed to soccer participation, and these were all 
musculoskeletal injuries consistent with participation in a contact sport 
(i.e., fibula fracture) with none occurring at known lesion sites. Overall, 
our results suggest that in a controlled trial setting, the benefits of ex-
ercise may outweigh perceived risks. Future research should include the 
number, type and severity of each adverse event using pre-established 
criteria (e.g., Common Terminology Criteria for Adverse Events) and 
record AEs in both the intervention and control groups (Services 
UDoHaH, 2009). 
Our findings support that the addition of unsupervised exercise for 
individuals with bone metastases may be safe, provided an element of 
supervised exercise instruction (i.e., individualized, in-person demon-
stration and practice) is initially included or regular check-in opportu-
nities with suitably qualified exercise professionals are provided. This is 
somewhat contrary to the summary from Nadler et al. that suggested 
only exercise in a supervised setting is safe (Nadler et al., 2019). In our 
review, 47% of trials included an element of unsupervised exercise. 
Inclusion of unsupervised exercise may improve access for individuals 
who face barriers to supervised exercise sessions, such as difficulty 
travelling due to functional impairments or immunocompromise, or lack 
of access due to location or cost (Sheill et al., 2018b). For supervised 
exercise, supervision was predominately provided by university-trained 
exercise professionals including clinical exercise physiologists and 
physical therapists/physiotherapists; consistent with the recently pub-
lished clinical guidance recommending that people with cancer with 
higher clinical needs should be referred to these highly qualified exer-
cise professionals (Schmitz et al., 2019). These findings provide a 
foundation for future research and clinical exercise programming for 
individuals with bone metastases to explore different models of delivery 
combined with qualified oversight (Cormie et al., 2018; Schmitz et al., 
2019; Body et al., 2016). 
To safely translate these research findings into clinical practice, 
understanding appropriate pre-exercise screening and exercise modifi-
cations is required. All RCTs included in this review used screening 
criteria that required either: 1) physician clearance prior to exercise; or 
2) a minimum level of functioning that included ambulation and basic 
self-care (e.g., ECOG 0-2 or KPS > 70); or 3) an absence of unstable bone 
metastases or pain related to lesion(s). Other screening approaches have 
been suggested in individuals with bone metastases to identify those at 
risk of a SAE (i.e., Mirels and Taneichi scales) (Maltser et al., 2017; 
Support, 2018; Nadler et al., 2019; Sheill et al., 2018c; Taneichi et al., 
1997; Mirels, 2003). However, only two studies in our review imple-
mented these tools, suggesting more research is required to confirm their 
utility for pre-exercise screening, especially for use in clinical practice 
(Rief et al., 2014a, b, c, d, 2016; Sprave et al., 2019). 
While the optimal exercise prescription for individuals with bone 
metastases is currently undefined, our review found that exercise pre-
scriptions predominantly fell within the levels recommended for in-
dividuals living with and beyond cancer by the American College of 
Sports Medicine (ACSM), including at least 90 minutes of moderate-to- 
vigorous intensity aerobic exercise and two days a week of resistance 
exercise (Campbell et al., 2019). The majority of trials (n = 14, 82%) 
included resistance training, which aligns with the clinical focus to 
preserve and increase physical function in individuals with bone me-
tastases (Cheville et al., 2016; Padgett et al., 2018). 
Moderate-to-vigorous exercise intensity was prescribed in the majority 
of trials, highlighting the capacity of individuals with bone metastases to 
perform increased exercise intensities that have been previously shown 
to be efficacious for cancer survivors (Campbell et al., 2019; Hayes et al., 
2019). 
Based on our findings, evidence on exercise modifications for in-
dividuals with bone metastases currently appears mixed, with 10 (59%) 
trials included in our review reporting no exercise modifications. Of 
note, all studies that included higher risk individuals with functional 
impairments, unstable metastases or bone pain used exercise modifica-
tions and no SAEs were reported (Cheville et al., 2019; Rief et al., 2014a, 
b, c, d, 2016; Sprave et al., 2019). More research and enhanced reporting 
of exercise intervention adherence is required to better define exercise 
recommendations, modifications and optimal exercise dose in in-
dividuals presenting with bone metastases. Some of this work has 
commenced to progress the evidence base for exercise effectiveness in 
people with bone metastases or advanced cancers (of which many will 
have bone metastases), including for cancer-specific endpoints such as 
delays to symptomatic skeletal events and disease progression, and 
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improvements to progression-free and overall survival (Brown et al., 
2019; Hart et al., 2017, 2018; Newton et al., 2018). This work has been 
made possible, in part, because of established safety and feasibility data 
in the literature that we have systematically reported in this review. 
Given the ability to explore the minimum effective dose, dose-response 
relationships, and various physiological effects of exercise modalities, 
intensities and volumes; it is now worthwhile for future research to 
examine the use of wearable technology and telemedicine delivery of 
exercise medicine to promote pragmatic randomised controlled trials 
and implementation efforts beyond the exercise clinic, and into the 
community setting (including people in rural and remote areas who are 
often disadvantaged). 
5. Strengths and Limitations 
The main strengths of this review are the systematic approach and 
the focus on including of controlled trials that recruited participants 
with bone metastases. However, only 645 participants (43%) had bone 
metastases, as such, results should be interpreted with caution. A key 
limitation of this review is that the majority of trials did not collect or 
report detailed information specific to bone metastases, specifically 
type, location, lesion size, treatments received and use of pain medica-
tion, limiting the translation of these findings into clinical practice. 
Finally, efficacy of the interventions could not be quantitatively evalu-
ated in this review, due to the variety of outcome measures used. Future 
controlled trials that specifically focus on individuals with bone me-
tastases are needed and are advised to include standardized reporting of 
AEs, have sufficient statistical power to determine intervention efficacy 
on person-centred outcomes, and include robust descriptions of the ex-
ercise prescription and bone-related modifications. 
6. Conclusions 
In the existing literature examining exercise in people with bone 
metastases, exercise appears to be safe and feasible, when it includes an 
element of supervised exercise instruction delivered by qualified exer-
cise professionals. More research is needed to understand the magnitude 
of effect that exercise can achieve in this population. 
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